image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Scapa

February 2019

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SCPA
  • Price:
  • 342p
Scapa’s repositioning from an industrial tapes business to one focused on the healthcare sector has hit a short-term bump as interim results showed pretax profit increasing just 2% to £17.1m while eps was unchanged at 8.3p. Sales fell 3.4% to £140.7m.The bugbear was the Healthcare side with profit decreasing almost 12% due to incremental investment made to execute technology transfers. The biggest of these was Systagenix’s flagship manufacturing site in North Yorkshire for £31.4m. It adds 22 R&D scientists, a new microbiology lab plus a dedicated gamma sterilization facility. Scapa has signed a five-year exclusive manufacturing contract for the majority of Systagenix’ advanced woundcare portf ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe